BIOMAT Database Logo BIOMAT Database Logo

Treatment of pyoderma gangrenosum associated with Crohn's disease. 2003

Toshihide Ohmori, and Akio Yamagiwa, and Itaru Nakamura, and Kou Nishikawa, and Abby R Saniabadi

UI MeSH Term Description Entries
D008297 Male Males
D003424 Crohn Disease A chronic transmural inflammation that may involve any part of the DIGESTIVE TRACT from MOUTH to ANUS, mostly found in the ILEUM, the CECUM, and the COLON. In Crohn disease, the inflammation, extending through the intestinal wall from the MUCOSA to the serosa, is characteristically asymmetric and segmental. Epithelioid GRANULOMAS may be seen in some patients. Colitis, Granulomatous,Enteritis, Granulomatous,Enteritis, Regional,Ileitis, Regional,Ileitis, Terminal,Ileocolitis,Crohn's Disease,Crohn's Enteritis,Inflammatory Bowel Disease 1,Regional Enteritis,Crohns Disease,Granulomatous Colitis,Granulomatous Enteritis,Regional Ileitides,Regional Ileitis,Terminal Ileitis
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006098 Granulocytes Leukocytes with abundant granules in the cytoplasm. They are divided into three groups according to the staining properties of the granules: neutrophilic, eosinophilic, and basophilic. Mature granulocytes are the NEUTROPHILS; EOSINOPHILS; and BASOPHILS. Granulocyte
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D012720 Severity of Illness Index Levels within a diagnostic group which are established by various measurement criteria applied to the seriousness of a patient's disorder. Illness Index Severities,Illness Index Severity
D016238 Cytapheresis Separation of one or more kinds of cells from whole blood with the return of other blood cell constituents to the patient or donor. This is accomplished with an instrument that uses centrifugation to separate the cells into different layers based on the differences in cell density (displacement) or drag coefficients in a current (elutriation). The procedure is commonly used in adoptive transfer to isolate NK cells, lymphocytes, or monocytes. Cytaphereses
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D017511 Pyoderma Gangrenosum An idiopathic, rapidly evolving, and severely debilitating disease occurring most commonly in association with chronic ulcerative colitis. It is characterized by the presence of boggy, purplish ulcers with undermined borders, appearing mostly on the legs. The majority of cases are in people between 40 and 60 years old. Its etiology is unknown.

Related Publications

Toshihide Ohmori, and Akio Yamagiwa, and Itaru Nakamura, and Kou Nishikawa, and Abby R Saniabadi
[Pyoderma gangrenosum associated with Crohn's disease].
January 1995, Vojnosanitetski pregled,
Toshihide Ohmori, and Akio Yamagiwa, and Itaru Nakamura, and Kou Nishikawa, and Abby R Saniabadi
Auricular pyoderma gangrenosum associated with Crohn's disease.
May 2012, La Tunisie medicale,
Toshihide Ohmori, and Akio Yamagiwa, and Itaru Nakamura, and Kou Nishikawa, and Abby R Saniabadi
Scrotal pyoderma gangrenosum associated with Crohn's disease.
December 2009, Singapore medical journal,
Toshihide Ohmori, and Akio Yamagiwa, and Itaru Nakamura, and Kou Nishikawa, and Abby R Saniabadi
Adalimumab treatment for peristomal pyoderma gangrenosum associated with Crohn's disease.
June 2009, Inflammatory bowel diseases,
Toshihide Ohmori, and Akio Yamagiwa, and Itaru Nakamura, and Kou Nishikawa, and Abby R Saniabadi
[Treatment with methylprednisolone bolus for pyoderma gangrenosum associated with Crohn's disease].
January 1992, Gastroenterologie clinique et biologique,
Toshihide Ohmori, and Akio Yamagiwa, and Itaru Nakamura, and Kou Nishikawa, and Abby R Saniabadi
Infliximab for treatment of resistant pyoderma gangrenosum associated with Crohn's disease.
December 2006, Acta dermatovenerologica Alpina, Pannonica, et Adriatica,
Toshihide Ohmori, and Akio Yamagiwa, and Itaru Nakamura, and Kou Nishikawa, and Abby R Saniabadi
[A case of Crohn's disease associated with pyoderma gangrenosum].
November 1997, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
Toshihide Ohmori, and Akio Yamagiwa, and Itaru Nakamura, and Kou Nishikawa, and Abby R Saniabadi
Treatment of pyoderma gangrenosum with infliximab in Crohn's disease.
September 2004, Digestive diseases and sciences,
Toshihide Ohmori, and Akio Yamagiwa, and Itaru Nakamura, and Kou Nishikawa, and Abby R Saniabadi
Pyoderma gangrenosum complicating Crohn's disease.
August 1977, The American journal of gastroenterology,
Toshihide Ohmori, and Akio Yamagiwa, and Itaru Nakamura, and Kou Nishikawa, and Abby R Saniabadi
[Pyoderma gangrenosum in Crohn's disease].
January 2008, Eksperimental'naia i klinicheskaia gastroenterologiia = Experimental & clinical gastroenterology,
Copied contents to your clipboard!